Eisai Clinical Trials

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures


Study Overview

May 2012 - Sep 2014
Partial-onset Seizures
The primary efficacy endpoint was the percent change in seizure frequency per 28 days during the Randomization Phase relative to the Prerandomization Phase (baseline).

  • Males and females (age 12 years and over)

  • Active, not recruiting

  • Phase 3

  • Australia, China, Japan, Korea, Republic of, Malaysia, Taiwan, Thailand See more


CSR Synopsis

Download PDF

Lay Summary

No download available

Publication reference citation

Nishida T, Lee SK, Inoue Y, Saeki K, Ishikawa K, Kaneko S. Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study. Acta Neurol Scand 2018 04;137(4):392-399. DOI: 10.1111/ane.12883

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

Redacted documents are available upon request for this study.

Document type Availability
Sample CRF
Full CSR